Feb 12, 2025, 15:37 by ASAM Weekly Editors

Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders

Feb 10, 2025, 16:59 by Sarah Shelson

Feb 10, 2025, 09:51 by ASAM Weekly Editors

Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl

Feb 7, 2025, 16:06 by Kelly Corredor

Feb 3, 2025, 16:30 by Sarah Shelson

Jan 31, 2025, 14:06 by Sarah Shelson

Jan 30, 2025, 00:00 by Sarah Shelson

Jan 29, 2025, 15:10 by Sarah Shelson

Jan 29, 2025, 11:18 by ASAM Weekly Editors

Beyond Buprenorphine in the ED: Leveraging Lessons From 10 Years of Implementation

Jan 27, 2025, 10:29 by Sarah Shelson

Jan 27, 2025, 05:00 by Kenneth Minkoff, MD

The opioid toxicity crisis remains an urgent public health priority across the US and Canada. Since the seminal randomized controlled trial published in 2015 found that buprenorphine initiation in the emergency department (ED) was superior compared with referral to treatment alone, buprenorphine initiation in the ED has been hailed as an important mechanism for addressing the overdose crisis.

Jan 27, 2025, 00:00 by Sarah Shelson

Jan 24, 2025, 17:04 by Sarah Shelson

Jan 24, 2025, 11:22 by Sarah Shelson

Jan 22, 2025, 10:08 by ASAM Weekly Editors

Current Advances in Behavioral Addictions

Jan 17, 2025, 17:23 by Sarah Shelson

Jan 16, 2025, 12:21 by Sarah Shelson

Jan 15, 2025, 12:58 by ASAM Weekly Editors

Review of Evidence on Alcohol and Health

Jan 9, 2025, 12:00 by Sarah Shelson

Jan 7, 2025, 12:06 by ASAM Weekly Editors

2024 ASAM Weekly Guest Editorials